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Background:  Because  measles  vaccination  prevents  acute  measles  disease  and  morbidities  secondary  to
measles,  such  as  undernutrition,  blindness,  and  brain  damage,  the  vaccination  may also  lead  to  higher
educational  attainment.  However,  there  has  been  little  evidence  to support  this  hypothesis  at  the  popu-
lation  level.  In this  study,  we estimate  the  causal  effect  of childhood  measles  vaccination  on  educational
attainment  among  children  born  between  1995  and  2000  in South  Africa.
Methods  and  ﬁndings:  We  use  longitudinal  data  on measles  vaccination  status  and  school  grade  attain-
ment  among  4783  children.  The  data  were  collected  by  the Wellcome  Trust  Africa Centre  Demographic
Information  System  (ACDIS),  which  is  one  of  Africa’s  largest  health  and  demographic  surveillance  sys-
tems. ACDIS  is located  in a poor,  predominantly  rural,  Zulu-speaking  community  in  KwaZulu-Natal,  South
Africa. Using  mother  ﬁxed-effects  regression,  we  compare  the  school  grade  attainment  of  siblings  who
are  discordant  in their  measles  vaccination  status  but  share  the same  mother  and household.  This  ﬁxed-
effects  approach  controls  for confounding  due  to  both  observed  and  unobserved  factors  that  do  not  vary
between siblings,  including  sibling-invariant  mother  and  household  characteristics  such  as  attitudes
toward  risk,  conscientiousness,  and  aspirations  for  children.  We  further  control  for  a range  of  potential
confounders  that  vary  between  siblings,  such  as sex of  the child,  year  of  birth,  mother’s  age at  child’s
birth,  and  birth  order.  We  ﬁnd  that measles  vaccination  on average  increases  school  grade  attainment  by
0.188 grades  (95%  conﬁdence  interval,  0.0424–0.334;  p = 0.011).
Conclusions:  Measles  vaccination  increased  educational  attainment  in this  poor,  largely  rural  community
in  South  Africa.  For  every  ﬁve  to seven  children  vaccinated  against  measles,  one  additional  school  grade
was  gained.  The  presence  of  a measles  vaccination  effect  in this  community  is  plausible  because  (i)  measles
vaccination  prevents  measles  complications  including  blindness,  brain  damage,  and undernutrition;  (ii)
a large  number  of number  of  children  were  at risk  of contracting  measles  because  of the  comparatively
low  measles  vaccination  coverage;  and  (iii)  signiﬁcant  measles  transmission  occurred  in  the  community
where  this  study  took  place  during  the study  observation  period.  Our  results  demonstrate  for  the ﬁrst
time that  measles  vaccination  affects  human  development  not  only  through  its  health  effects  but  also
through  its effects  on  education.
Published  by Elsevier  Ltd.  This  is  an open  access  article  under  the  CC  BY  license  (http://
Abbreviations: CI, conﬁdence interval; DSA, demographic surveillance area; DTP,
iphtheria–tetanus–pertussis vaccine; DTP3, complete series of three DTP doses; FE,
xed effects; HDSS, health and demographic surveillance system; MDG, Millennium
evelopment Goal; SD, standard deviation.
∗ Corresponding author at: USDA Economic Research Service, 1400 Independence
ve., SW,  Mail Stop 1800, Washington, DC 20250, USA. Tel.: +1 6463218222.
E-mail address: anekwe@post.harvard.edu (T.D. Anekwe).
ttp://dx.doi.org/10.1016/j.vaccine.2015.04.072
264-410X/Published by Elsevier Ltd. This is an open access article under the CC BY licencreativecommons.org/licenses/by/4.0/).
1. Introduction
Childhood vaccinations are among the most cost-effective pub-
lic health interventions [1,2], yet coverage for several vaccinations
is far from universal in many countries [3]. In this paper, we focus
on measles vaccination for several reasons. Measles vaccination
coverage remains low in sub-Saharan Africa; in many countries
in the region [4], coverage is far below the 93–95% required for
se (http://creativecommons.org/licenses/by/4.0/).
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erd immunity [5]. For instance, measles vaccination coverage
among one-year-olds) in South Africa is only 66% [6], in the WHO
frican Region only 73% [7], and in KwaZulu-Natal, South Africa
where this study took place), overall 77% but with signiﬁcant vari-
tion in coverage across communities [8]. As a result, populations
n South Africa are vulnerable to measles, and endemic measles
ransmission and measles outbreaks have been common [9–11].
easles kills more people in the WHO  African Region than any
ther vaccine-preventable disease such as pertussis, diphtheria, or
etanus (36,900 children under ﬁve each year) [12].
Vaccinations improve health outcomes, but it is also plau-
ible that they improve non-health outcomes via those health
mprovements [13,14]. By warding off diseases and subsequent
omplications (such as undernutrition, blindness, and encephali-
is), vaccinations may  protect children’s cognitive and physical
evelopment, which in turn enhances their capacity for educational
ttainment, labor market productivity, harnessing life chances, and
ulﬁlling social roles [15–19].
Educational attainment is a particularly important potential
utcome of measles vaccination. Education is a human right
20,21]; it is also essential for human development, as it expands
eople’s life chances and capabilities [22]. Furthermore, education
s instrumentally important because it can improve labor produc-
ivity, which fuels economic development [23–25]. The importance
f education is underscored by the fact that the United Nations
evelopment Programme has for decades been using educational
ttainment as one of the three components of its Human Devel-
pment Index [26,27]. Despite the fundamental importance of
ducation for people and societies, average educational attainment
n many places remains low. For instance, educational attainment in
outh Asia and sub-Saharan Africa is less than ﬁve years [26]—well
elow the level of secondary school, which begins at grade seven
n many countries [28].
Despite the fact that measles vaccination prevents a variety of
isabling health conditions that are likely to affect educational
ttainment (e.g., blindness [29], measles encephalitis and sub-
equent neurological damage [30,31], and child undernutrition
30,32,33]) and the general interest in vaccination effects on edu-
ation [15], no study has to date tried to establish the effect of
easles vaccination on educational attainment. With this study,
e aim to close this evidence gap. We  estimate the causal effect of
hildhood measles vaccination on educational attainment among
hildren born between 1995 and 2000 in a poor, predominantly
ural community in KwaZulu-Natal, South Africa.
. Methods
.1. Data sources and samples
We  used longitudinal data from a health and demographic
urveillance system (HDSS) in rural KwaZulu-Natal, South Africa,
hat was established and is maintained by the Wellcome Trust-
unded Africa Centre for Health and Population Studies. The HDSS
tarted in 2000 and covers a demographic surveillance area (DSA)
f 438 square kilometers near the market town of Mtubatuba in the
redominantly rural Umkhanyakude district of KwaZulu-Natal. The
urveillance system covers the entire population of about 85,000
ulu-speaking people who are members of the 11,000 house-
olds in the DSA. Most households are multi-generational, and
verage household size is 7.9 (SD = 4.7) members. Although this
s a predominantly rural area, the principal source of income for
ost households is waged employment and state pensions ratherhan agriculture. In 2006, approximately 77% of households in the
urveillance area had access to piped water and toilet facilities [34].
ue to the availability of antiretroviral therapy in South Africa’s
ublic-sector health system starting in 2004, adult life expectancy3 (2015) 5020–5026 5021
in this community increased from about 49 years in 2003 to 61
years in 2011 [35].
Data on all births in the year of a household’s ﬁrst interview in
the surveillance as well as the previous ﬁve years were elicited from
all women  residing in the DSA. For each child, childhood vaccina-
tion data were elicited. We  measured the outcome, school grade
attainment, up to the year 2007. Our sample for this study con-
sists of all children who were born between 1995 and 2000 and
were members of households residing in the DSA in 2007. 1995
was the ﬁrst year that childhood vaccination data became avail-
able in the HDSS; the year 2000 cutoff ensures that every child
had the chance to complete at least one year of school by 2007 in
longitudinal follow-up.
In the sample for complete-case analysis, the total number of
children was  4783 and the total number of mothers was 4080. In
the sample for multiple-imputation analysis, the total number of
children was  7509 and the total number of mothers was  6148. Even
though the main effect estimate in our ﬁxed-effects models is based
only on the comparison of children who share the same mother but
differ in their measles vaccination status (607 in the complete-case
analysis and 1031 in the multiple-imputation analysis), we  kept all
other children in the sample for analysis, because these observa-
tions contribute to the estimation of the regression constant and the
R2 statistic without affecting the size or signiﬁcance of the measles
effect estimate.
The surveillance questionnaires and descriptions of the data sets
are available on the website of the Africa Centre for Health and
Population Studies (http://www.africacentre.ac.za).
2.2. Exposure and outcome variables
2.2.1. Vaccination status
Our exposure variable is measles vaccination status at 12
months of age. A child was coded as either vaccinated or unvacci-
nated for measles by 12 months of age. We coded a child as having
received his or her measles dose by 12 months of age if at least
one of the following two  conditions was met: ﬁrst, the national
vaccination card (the so-called Road-to-Health card) was the data
source and the date of vaccination dose was  within one year of
birth or, second, mother’s report was  the data source and indi-
cated that the child had received the vaccination within one year
of birth. Mother’s report of her children’s vaccination status has
been validated in this community by Ndirangu et al. [36]. If vaccina-
tion card information and mother’s report were both available, we
used the card information. This approach to coding vaccination data
is the same that is used in many other population-based surveys,
such as the Demographic and Health Surveys (DHS) [37]. Children
with missing card information and missing mother’s report and
children with missing covariate information were excluded in the
complete-case analyses. To test the robustness of our ﬁndings to
missing observations, we  multiply imputed vaccination status and
other missing data and repeated the analyses with the imputed
datasets [38]. The sample size for the main, complete-case analysis
was 4783; the sample size for the analysis of the multiply imputed
data was  7509.
2.2.2. Educational attainment
To capture educational attainment, we used the highest school
grade that a child had attained at the last HDSS household interview
up to the year 2007. Not all children were eligible for outcome mea-
surement in 2007 (e.g., because their families had out-migrated). To
ensure the comparability of school grade outcomes between chil-
dren who were born in the same year but had their school grade
measured in different years, we  controlled for a child’s age at start
of the school year in which the household interview was  conducted.
Also, to ensure the comparability of schooling outcomes between
5 ccine 
c
t
m
e
c
W
g
s
y
c
t
t
w
2
e
m
t
a
c
c
a
c
b
f
(
t
c
f
t
s
i
s
v
c
s
e
g
Y
w
i
p
b
m
m
a
w
p
c
u
f
o
a
i
m
i
e
c
c
T
attainment (in the complete-case analyses) and by an additional
0.143–0.149 years of school grade attainment (in the analyses
after multiple imputation), compared to siblings who  were not
Table 1
Descriptive statistics.
Complete-case
analysis
Multiple-imputation
analysis
Sample size 4783 7509
School grade, mean (SD)
Grade 2.3 (1.6) 2.4 (1.7)
Grade-for-age −0.98 (1.1) −1.00 (1.1)
Measles vaccination at 12 months of age, % (SD)
No 34.4 (47.5) 25.4 (43.5)
Yes 65.6 (47.5) 74.6 (43.5)
Sex, % (SD)
Female 49.7 (50.0) 50.2 (50.0)
Male 50.3 (50.0) 49.8 (50.0)
Age,a % (SD)
6 17.8 (38.3) 17.5 (38.0)
7  18.0 (38.4) 16.8 (37.4)
8  18.9 (39.2) 17.6 (38.1)
9  18.5 (38.9) 18.0 (38.4)
10  15.0 (35.7) 16.0 (36.6)
11  11.7 (32.2) 14.1 (34.8)
Birth cohort, % (SD)
1995 13.7 (34.3) 16.6 (37.2)
1996 16.8 (37.4) 17.6 (38.1)
1997 19.5 (39.7) 19.1 (39.3)
1998 19.4 (39.5) 17.6 (38.0)
1999 16.4 (37.0) 15.0 (35.8)
2000 14.2 (34.9) 14.1 (34.8)
Mother’s age at child’s birth (years), % (SD)
<18 7.8 (26.9) 8.7 (28.2)
18–19 9.8 (29.7) 10.2 (30.3)
20–24 26.6 (44.2) 25.9 (43.8)
25–29 21.9 (41.4) 21.9 (41.4)
30–34 17.3 (37.8) 17.2 (37.8)
≥35 16.6 (37.2) 16.1 (36.7)
Birth order, % (SD)
1st 33.5 (47.2) 34.1 (47.4)
2nd 20.4 (40.3) 20.7 (40.5)
3rd 14.6 (35.3) 14.3 (35.0)
4th 11.1 (31.5) 11.0 (31.3)
5th 8.2 (27.5) 7.8 (26.8)
6th 5.7 (23.3) 5.5 (22.9)
7th or later 6.4 (24.4) 6.6 (24.9)
DTP vaccination at 12 months of age, % (SD)
0  DTP doses 12.4 (33.0) 10.1 (30.1)
1  DTP dose 3.3 (17.9) 2.8 (16.5)
2  DTP doses 5.3 (22.4) 4.6 (20.9)
3  DTP doses 79.0 (40.7) 82.6 (37.9)022 T.D. Anekwe et al. / Va
hildren who were born in different calendar years (and who  would
herefore be expected to have different levels of school grade attain-
ent in later calendar years), we controlled for year of birth. We
xcluded a small number of children (49, or 1.0% of the complete-
ase analysis sample) who had implausible reported grade levels.
e deﬁned “implausible reported grade level” as three or more
rades ahead of the grade that a child would have attained had she
tarted school (grade 1) at age seven and advanced by one grade per
ear. (According to the South African Schools Act of 1996 [39,40],
hildren must start school no later than the calendar year in which
hey turn seven years old.) At the time of the last measurement of
he outcome in this study (school grade attainment), the children
ere aged six to eleven years.
.3. Statistical analysis
We  estimate the effect of childhood measles vaccination on
ducational attainment using mother ﬁxed-effects analysis. The
other ﬁxed effects control for all observed and unobserved factors
hat are shared by siblings, including mother and household char-
cteristics that do not vary between siblings, such as risk attitudes,
onscientiousness, and aspirations for children’s futures. We  also
ontrol for a number of factors that can vary between siblings: sex,
ge at start of the school year in which the household interview was
onducted, calendar year of birth, mother’s age at child’s birth, and
irth order. Finally, in separate analyses, we additionally control
or the number of doses of diphtheria–tetanus–pertussis vaccine
DTP) received. DTP is often used as a proxy for immunization sys-
em performance [41]. Here, DTP coverage serves as a powerful
ontrol variable to account for any potential sibling-varying con-
ounding that is related to differences between siblings in access
o vaccinations in general that are not captured by the other
ibling-varying control variables. These sibling-varying confound-
ng factors include differential availability of vaccination between
iblings that is not already captured by the calendar-year control
ariables (e.g., when a family moves their home closer to a vac-
ination clinic and at the same time moves closer to the nearest
chool). They also include changes in maternal and paternal knowl-
dge, attitudes, and behaviors that can affect vaccination and school
rade attainment.
The mother ﬁxed-effects regression has the form:
im =  ˛ + ˇVim + Xim + Xm + m + εim (1)
here Yim is the school grade of child i with mother m. Vim is child
’s measles vaccination status at 12 months of age.  ˇ is the main
arameter of interest in this study: the conditional association
etween childhood measles vaccination and school grade attain-
ent. Xim is a vector of child i’s characteristics, and Xm is mother
’s  age at the time of child i’s birth. m is the mother ﬁxed effect
nd im is the error term.
We performed four regression analyses: complete-case analyses
ith and without the DTP covariates and analyses using multi-
le imputation of missing data, again both with and without DTP
ovariates. Some data were missing for four of the variables we
se in the regression analyses: school grade attainment (missing
or 69 of 7509 observations), measles vaccination (missing for 100
bservations), DTP vaccination (missing for 2600 observations),
nd birth order (missing for 117 observations). We  carried out 40
mputations in the multiple imputation, which exceeds the com-
only recommended minimum numbers of imputations [42] but
s unproblematic given today’s computing power.
In all models, we clustered heteroskedasticity-robust standardrrors at the level of the mother to account for correlation in out-
omes among children who  share the same mother. Analyses were
onducted using Stata version 11 (StataCorp LP, College Station,
X).33 (2015) 5020–5026
3. Results
Table 1 presents descriptive statistics for both the analyses using
the complete-case sample and the analyses after multiple imputa-
tion. Measles vaccination coverage at 12 months of age was 66%
in the complete-case analysis and average school grade attainment
was 2nd grade (Table 1). On average, children were about one year
behind the school grade attainment they would be expected to
have reached by the time of the last school grade assessment in
this study, had they progressed through the grades without delay
since entering school. Table 2 presents the estimates of the causal
effect of measles vaccination on school grade attainment, control-
ling for mother ﬁxed effects (FE). Our results show that childhood
measles vaccination signiﬁcantly increases school grade attain-
ment: children vaccinated against measles by 12 months of age
beneﬁt on average by an additional 0.188 years of school gradeDue to rounding, not all percentages add up to 100%. SD = standard deviation; DTP
=  diphtheria-tetanus-pertussis vaccine.
a Age at start of the school year in which the latest available household interview
was conducted.
T.D. Anekwe et al. / Vaccine 33 (2015) 5020–5026 5023
Table  2
Mother ﬁxed-effects regressions of school grade attainment on measles vaccination status and control variables.
Variables (1) (2) (3) (4)
Complete-case analysis
without DTP3 covariate:
beta-coefﬁcient estimate
(95% CI) p-value
Complete-case analysis with
DTP3 covariate:
beta-coefﬁcient estimate
(95% CI) p-value
Multiple imputation without
DTP3 covariate:
beta-coefﬁcient estimate
(95% CI) p-value
Multiple imputation with DTP3
covariate: beta-coefﬁcient
estimate
(95% CI) p-value
(Reference category: no measles vaccination)
Measles vaccination 0.188
(0.0424, 0.334) p = 0.011
0.188
(0.0197, 0.355) p = 0.029
0.149
(0.0419, 0.257) p = 0.006
0.143
(0.0108, 0.276) p = 0.034
Female 0.314
(0.194, 0.434) p < 0.001
0.315
(0.195, 0.436) p < 0.001
0.282
(0.192, 0.371) p < 0.001
0.282
(0.192, 0.371) p < 0.001
(Reference category: 8 years olda)
6 years old −0.893
(−1.396, −0.390) p = 0.001
−0.900
(−1.399, −0.400) p < 0.001
−1.217
(−1.595, −0.839) p < 0.001
−1.220
(−1.598, −0.841) p < 0.001
7  years old −0.447
(−0.758, −0.136) p = 0.005
−0.442
(−0.755, −0.130) p = 0.006
−0.662
(−0.895, −0.428) p < 0.001
−0.662
(−0.896, −0.428) p < 0.001
9  years old 0.914
(0.605, 1.223) p < 0.001
0.900
(0.587, 1.213) p < 0.001
0.795
(0.550, 1.041) p < 0.001
0.792
(0.545, 1.038) p < 0.001
10  years old 1.624
(1.191, 2.057) p < 0.001
1.627
(1.194, 2.060) p < 0.001
1.727
(1.369, 2.084) p < 0.001
1.729
(1.370, 2.087) p < 0.001
11  years old 2.450
(1.863, 3.038) p < 0.001
2.435
(1.845, 3.025) p < 0.001
2.283
(1.764, 2.802) p < 0.001
2.283
(1.763, 2.803) p < 0.001
(Reference category: Born in 1997)
Born in 1995 −0.227
(−0.710, 0.257) p = 0.358
−0.222
(−0.705, 0.262) p = 0.369
−0.0866
(−0.497, 0.323) p = 0.679
−0.0885
(−0.499, 0.322) p = 0.672
Born  in 1996 −0.0718
(−0.428, 0.284) p = 0.693
−0.0803
(−0.436, 0.275) p = 0.658
−0.174
(−0.437, 0.0890) p = 0.194
−0.178
(−0.442, 0.0864) p = 0.187
Born  in 1998 0.268
(−0.0426, 0.580) p = 0.091
0.265
(−0.0504, 0.580) p = 0.100
0.0822
(−0.161, 0.326) p = 0.508
0.0810
(−0.164, 0.326) p = 0.517
Born  in 1999 0.132
(−0.322, 0.586) p = 0.568
0.116
(−0.346, 0.578) p = 0.622
0.104
(−0.243, 0.451) p = 0.557
0.0989
(−0.250, 0.448) p = 0.578
Born  in 2000 −0.0387
(−0.715, 0.638) p = 0.911
−0.0397
(−0.717, 0.638) p = 0.909
0.0330
(−0.484, 0.550) p = 0.900
0.0330
(−0.484, 0.550) p = 0.901
(Reference category: Mother’s age at birth: 20–24 years)
<18 years −0.134
(−0.639, 0.371) p = 0.603
−0.142
(−0.654, 0.370) p = 0.586
−0.187
(−0.565, 0.191) p = 0.331
−0.189
(−0.567, 0.190) p = 0.328
18–19  years 0.121
(−0.228, 0.469) p = 0.496
0.107
(−0.246, 0.459) p = 0.554
−0.0366
(−0.288, 0.215) p = 0.776
−0.0384
(−0.291, 0.214) p = 0.766
25–29  years 0.0281
(−0.231, 0.287) p = 0.831
0.0327
(−0.226, 0.292) p = 0.805
−0.0903
(−0.304, 0.124) p = 0.408
−0.0864
(−0.300, 0.127) p = 0.428
30–34  years −0.116
(−0.528, 0.296) p = 0.582
−0.121
(−0.530, 0.288) p = 0.562
−0.237
(−0.556, 0.0821) p = 0.145
−0.235
(−0.554, 0.0840) p = 0.149
≥35  years −0.407
(−1.036, 0.221) p = 0.204
−0.392
(−1.019, 0.235) p = 0.221
−0.503
(−0.977, −0.0282) p = 0.038
−0.496
(−0.970, −0.0213) p = 0.041
(Reference category: Birth order: 1st child)
2nd child −0.478
(−0.740, −0.216) p < 0.001
−0.479
(−0.741, −0.216) p < 0.001
−0.307
(−0.486, −0.128) p = 0.001
−0.307
(−0.486, −0.128) p = 0.001
3rd  child −0.766
(−1.232, −0.301) p = 0.001
−0.773
(−1.238, −0.307) p = 0.001
−0.445
(−0.740, −0.150) p = 0.003
−0.445
(−0.741, −0.149) p = 0.003
4th  child −1.302
(−1.931, −0.673) p < 0.001
−1.319
(−1.949, −0.688) p < 0.001
−0.636
(−1.032, −0.241) p = 0.002
−0.636
(−1.033, −0.240) p = 0.002
5th  child −1.701
(−2.488, −0.914) p < 0.001
−1.721
(−2.509, −0.933) p < 0.001
−0.821
(−1.317, −0.326) p = 0.001
−0.825
(−1.323, −0.326) p = 0.001
6th  child −2.071
(−3.022, −1.121) p < 0.001
−2.084
(−3.034, −1.134) p < 0.001
−0.871
(−1.462, −0.280) p = 0.004
−0.870
(−1.464, −0.277) p = 0.004
7th  child or later −2.495
(−3.645, −1.346) p < 0.001
−2.511
(−3.659, −1.363) p < 0.001
−0.994
(−1.695, −0.292) p = 0.006
−0.990
(−1.694, −0.286) p = 0.006
(Reference category: 3 DTP doses)
0 DTP doses −0.0219
(−0.259, 0.216) p = 0.857
−0.00176
(−0.211, 0.208) p = 0.987
1  DTP doses 0.282
(−0.0953, 0.659) p = 0.143
0.0676
(−0.268, 0.403) p = 0.693
2  DTP doses −0.170
(−0.478, 0.137) p = 0.277
−0.107
(−0.369, 0.155) p = 0.422
Adjusted R2 0.743 0.743 0.618 0.618
Number of children 4783 4783 7509 7509
Number of mothers 4080 4080 6148 6148
Number of children with measles
vaccination-discordant siblings
607 607 1031 1031
C
.
m
ﬁ
e
cI = conﬁdence interval; DTP = diphtheria-tetanus-pertussis vaccine.
a Age at start of the school year in which the household interview was  conductedeasles-vaccinated by 12 months of age. In other words, for every
ve to seven children receiving the measles vaccination, we would
xpect to gain one full year of school grade attainment among
hildren aged between six and eleven years. When we add DTPvaccination status as an additional control variable, the results
remain essentially unchanged.
We also performed a sensitivity analysis to test whether our
ﬁndings were robust when we included in the treatment group
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hose children who received measles with a one-month delay (i.e.,
etween 12 and 13 months). The results of this analysis are essen-
ially the same as those of the main analysis: The measles effect
ize estimate was 0.176 [p-value 0.020; 95% CI = (0.028, 0.324)] in
he complete-case analysis without DTP3 covariate; 0.171 [p-value:
.051; 95% CI = (−0.0006, 0.342)] in the complete-case analysis
ith DTP3 covariate; 0.130 [p-value: 0.019; 95% CI = (0.021, 0.239)]
n the multiple-imputation analysis without DTP3 covariate; and
.114 [p-value: 0.102; 95% CI = (−0.023, 0.251)] in the multiple-
mputation analysis with DTP3 covariate.
Taking an estimate of an 11.7% gain in wages per year of school-
ng in sub-Saharan Africa [43] and the measles vaccination effect
n years of schooling established in this study (0.188), we estimate
hat a child who is currently not vaccinated against measles would
e expected to gain a more than 2% wage increase per year from
easles vaccination.
. Discussion
We  ﬁnd that measles vaccination signiﬁcantly increases edu-
ational attainment in a predominantly rural community in South
frica with comparatively low measles vaccination coverage. Our
esults indicate that for every ﬁve to seven children vaccinated
gainst measles by 12 months of age, one additional year of school-
ng is gained. Based on estimated wage returns to education [43],
his effect translates into an annual wage gain of more than 2%
ue to measles vaccination. Because the children in this sample are
uite young (six to eleven years of age), the ﬁnal schooling deﬁcit
mong the unvaccinated may  be even larger than that found in this
tudy.
Our ﬁnding that measles vaccination substantially affects
hildren’s school grade attainment is plausible. Measles vaccina-
ion prevents blindness, which can severely impede educational
ttainment, particularly in settings where schools for the blind
re not available [29]. Measles vaccination can also prevent
easles encephalitis and its sequelae, which include neurolog-
cal damage [30,31]; middle ear infections, which can lead to
earing impairment and scholastic underperformance [44]; and
hild undernutrition [30,32,33], which predicts lower educa-
ional attainment and worse academic performance in developing
ountries [45,46]. Furthermore, infections and undernutrition
n children under ﬁve can cause general malaise, apathy, and
ecreased physical activity and play [47,48]; young children with
hese symptoms generally receive less stimulation from adults and
ewer learning opportunities, which can negatively impact their
ognitive and physical development [48].
The educational effect of measles vaccination is likely to be
elatively large in poor communities, such as the one where this
tudy took place, because high underlying levels of undernutri-
ion weaken the immune system and exacerbate the severity of
easles disease and measles complications [49,50]. The educa-
ional effect of measles vaccination may  also be more pronounced
n communities where assistive technology and special education
or the disabled [51] are largely lacking, as is the case in the study
ommunity. In South Africa in general, students with learning dis-
bilities and other special needs face major barriers to educational
ccess and performance: many schools lack the infrastructure and
esources to accommodate students with disabilities, and edu-
ators are not trained or equipped to work with students with
isabilities in the classroom. A student’s failure to master the cur-
iculum can result in grade repetition, which is a major cause of
ver-age enrollment in South Africa’s schools. Over-age enrollment
nd special educational needs have been identiﬁed as risk factors
or dropping out of school in South Africa [52].
A recent study [8] found children aged 12–23 months in this
ommunity had 77% measles vaccination coverage in 2006—far33 (2015) 5020–5026
below the herd immunity threshold (93–95%), thus leaving
the community vulnerable to signiﬁcant measles incidence and
outbreaks. Indeed, data from the South African national epidemi-
ological reporting system show signiﬁcant measles transmission
during the period of the present study [10,11]. Although we do not
have information on the incidence of measles infection and compli-
cations for children in our particular sample, it seems likely that a
number of children contracted measles throughout the period 1995
through 2007 due to the low measles vaccination coverage rates
and the epidemiological evidence of continued measles transmis-
sion [53].
The causal effect of measles vaccination on educational attain-
ment can never be estimated in a randomized experiment, because
it is obviously unethical to withhold a vaccination of proven
effectiveness and safety. When randomized experiments are not
possible, quasi-experimental studies are a powerful alternative
for strong causal evaluation. We  thus use a quasi-experimental
approach (mother ﬁxed-effects analysis) to estimate the effect
of childhood measles vaccination on educational attainment. The
identifying assumption of this analysis is that vaccination status
among siblings is as good as randomly assigned after controlling
for all sibling-invariant mother and household characteristics and
several sibling-varying factors that might confound the relation-
ship between sibling vaccination status and educational attainment
(e.g., birth cohort, mother’s age at birth, and birth order). We  also
control for the sibling-varying factor DTP vaccination, a proxy for
DTP coverage that powerfully controls for potential sibling-varying
confounding factors that determine vaccination status in general
rather than speciﬁcally for measles.
Outside of a randomized controlled trial, a mother ﬁxed-
effects study that controls for a range of potentially important
sibling-varying confounders is among the strongest types of causal
inference strategies available to answer the question of whether
a childhood vaccination has an effect on educational attainment
[54]. One likely reason why  such a quasi-experimental study has
not been previously carried out is that such studies need very large
sample sizes in order to have sufﬁcient power to detect signiﬁ-
cant effects. Our sample size here is large and proved large enough
to detect a highly signiﬁcant measles vaccination effect on edu-
cational attainment in a rural community in South Africa where
measles vaccination coverage is overall low. This data analytical
opportunity arose because we had access to a large longitudinal,
population-based dataset, which includes all children born from
1995 through 2000 to mothers who  lived in a community of about
85,000 people in 2000. Measles vaccination coverage in the com-
munity is comparatively low, and our dataset included an overall
large number of those children who  contribute to the effect size
estimation in mother ﬁxed-effects analysis: children who  have at
least one measles vaccination-discordant sibling.
Our study has several limitations. A ﬁrst limitation is that, given
our identiﬁcation strategy, we  do not capture the herd effects
of measles vaccination on educational attainment (i.e., that some
unvaccinated children may  beneﬁt in their educational attainment
because of the vaccination of others). The full causal impact of
measles vaccination on educational attainment in the community
is thus likely larger than the effect size we have estimated in this
study, and future studies estimating the social value of measles vac-
cination should treat this effect size as a lower bound of the true
educational beneﬁt of measles vaccination [55]. A second limita-
tion is that we do not have information on children’s HIV status.
HIV-positive children may  be less likely to receive vaccination
(e.g., because of illness or stigma) [8] and less likely to perform
well in school (e.g., because of HIV-related diseases). Similarly,
because of HIV stigma, an HIV-infected child within the family
may  have adverse consequences on siblings, including access to
immunization. However, antiretroviral treatment did not become
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vailable in this community until the end of 2004 and did not reach
igniﬁcant population coverage until the end of 2006 [56]. It is
hus unlikely that many children in our sample (born 1995–2000)
ho were infected in the perinatal period survived to school age
57]. In addition, as sexual debut is relatively late in South Africa,
t is further unlikely that a signiﬁcant number of children in the
ample were infected through sexual transmission. According to a
ationally representative study in 2002, in the age group 12–14
ears, only 1.9% of males and 1.5% of females reported having had
ex [58]. Finally, only a very small proportion of children who
ere infected with HIV through sexual transmission would have
eveloped HIV-related symptoms by the time their school grade
ttainment was observed in this study, due to the long latency of
IV [59].
A third limitation is the possibility that disease may  have caused
hildren to both miss vaccinations at the clinic and do poorly in
chool. However, since in this study we observe measles vaccina-
ion exposures and school grade outcomes six to ten years apart,
nly childhood diseases (or disease symptoms) that last many
ears without causing death could have had such a confounding
ffect, and such diseases are overall rare. A fourth limitation is that
ur ﬁxed-effects model relies on vaccination status-discordant sib-
ings (i.e., at least one sibling is vaccinated and at least one other
s unvaccinated) and is therefore unable to examine the causal
ffect of measles vaccination on educational attainment among
amilies with only one child. Consequently, our estimates may
e generalizable only to families with two or more children. Fur-
hermore, because our identiﬁcation strategy relies on households
here at least one sibling is vaccinated and at least one sibling
s unvaccinated, and because of cross-sibling herd effects [60],
n unvaccinated sibling in our study is partially protected from
easles infection by his or her sibling’s measles vaccination. In
ther words, our control group is partially protected from measles.
his means that our estimated effect size is a lower bound on the
rue effect size for children in multi-child families where none of
he children are vaccinated against measles.
Results from a sensitivity analysis of delayed measles vaccina-
ion (by 1 month) support our main ﬁndings. It is important to
ote that as measles vaccination is increasingly delayed the risk of
cquiring measles increases. In contexts where measles vaccination
overage remains relatively low, such as in rural KwaZulu-Natal,
he impact of “catch-up” and “mop-up” [61] campaigns is an impor-
ant policy question. Future research in areas where there has been
ubstantial variation in such strategies could follow our basic ana-
ytical approach here to establish campaign impact on educational
ttainment [61–63].
In order to better understand how vaccine-preventable dis-
ase is linked to educational attainment, we also suggest that
uture research use child-level data to examine the relationships
etween childhood infectious disease and subsequent complica-
ions (occurrence, timing, type, and severity), entry into school
late, on-time, and early), and grade progression (slow, normal, and
ast). Such detailed analyses could establish the causal pathways
rom measles vaccination to educational attainment. Although we
rgue in this paper that measles and its sequelae mediate the
elationship between measles vaccination status and educational
ttainment, our data do not permit us to investigate this question
irectly.
The returns to primary education in developing countries are
ery high. In fact, both the social and private returns to primary
ducation are substantially higher than those to secondary or ter-
iary education, and they are higher in developing countries than in
eveloped countries [43]. In this study, we have therefore focused
n the causal effect of measles vaccination on children’s educa-
ional attainment in primary school. In future work, we plan to
xtend this analysis to also study the effect of childhood measles
[
[3 (2015) 5020–5026 5025
vaccination on education and labor market outcomes in older
ages.
Achieving universal coverage with vaccinations of proven effec-
tiveness is desirable for many reasons, foremost to save lives and
prevent disease. Because global child mortality could be substan-
tially reduced if all children received the measles vaccine, the fourth
Millennium Development Goal (MDG) calls for reduction of child
mortality to be achieved in part by increasing the proportion of
one-year-old children immunized against measles. But our ﬁndings
suggest that measles vaccination would also boost progress toward
the second MDG, which calls for universal primary education.
Finally, because education can promote the development of pro-
ductive and innovative adults, higher measles vaccination coverage
rates could accelerate nations’ human and economic development.
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